Osmotic and hypoxic induction of osteopontin in retinal pigment epithelial cells: Involvement of purinergic receptor signaling.


Journal

Molecular vision
ISSN: 1090-0535
Titre abrégé: Mol Vis
Pays: United States
ID NLM: 9605351

Informations de publication

Date de publication:
2020
Historique:
received: 14 05 2019
accepted: 06 03 2020
entrez: 28 3 2020
pubmed: 28 3 2020
medline: 5 2 2021
Statut: epublish

Résumé

Osteopontin (OPN) is a neuroprotective factor in the retina that improves photoreceptor survival. The aim of the present study was to investigate whether human RPE cells express and respond to OPN. Hypoxia and chemical hypoxia were induced by cell culture in 0.25% O The acutely isolated RPE cells and the cultured RPE cells expressed The data indicated that RPE cells produce and respond to OPN;

Identifiants

pubmed: 32214785
pmc: PMC7086046

Substances chimiques

NFAT5 protein, human 0
Purinergic Agonists 0
RNA, Small Interfering 0
Receptors, Purinergic 0
Transcription Factors 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
Osteopontin 106441-73-0
fibroblast growth factor 13 330E71H5Q4
Sodium Chloride 451W47IQ8X
Fibroblast Growth Factors 62031-54-3
Adenosine Triphosphate 8L70Q75FXE
CREB-Binding Protein EC 2.3.1.48
CREBBP protein, human EC 2.3.1.48
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24
Phospholipases A2 EC 3.1.1.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-203

Informations de copyright

Copyright © 2020 Molecular Vision.

Références

Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):583-91
pubmed: 19084984
Trends Neurosci. 2009 Mar;32(3):128-41
pubmed: 19232752
Ophthalmology. 2004 Jun;111(6):1169-75
pubmed: 15177967
PLoS One. 2016 Oct 27;11(10):e0165653
pubmed: 27788256
Exp Eye Res. 1998 Sep;67(3):283-92
pubmed: 9778409
Mol Vis. 2016 Dec 22;22:1437-1454
pubmed: 28031693
PLoS One. 2011;6(12):e27674
pubmed: 22194789
J Neurosci. 1995 Nov;15(11):7377-85
pubmed: 7472491
Oncogene. 2009 Sep 24;28(38):3412-22
pubmed: 19597469
J Hirnforsch. 1997;38(2):223-9
pubmed: 9176734
Prog Retin Eye Res. 2016 Mar;51:69-89
pubmed: 26344735
Eur J Cell Biol. 2011 Aug;90(8):642-8
pubmed: 21616556
Am J Respir Cell Mol Biol. 2009 Sep;41(3):290-6
pubmed: 19151319
Lung Cancer. 2007 Sep;57(3):302-10
pubmed: 17482311
Mol Metab. 2014 Mar 22;3(4):384-93
pubmed: 24944898
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10673-8
pubmed: 15247420
Exp Eye Res. 2004 Aug;79(2):239-47
pubmed: 15325571
J Phys Chem B. 2017 Jun 22;121(24):5968-5976
pubmed: 28585833
Jpn J Ophthalmol. 2002 May-Jun;46(3):270-8
pubmed: 12063036
Brain Res Dev Brain Res. 1996 Jun 14;94(1):92-8
pubmed: 8816281
Ophthalmology. 2003 Jun;110(6):1273-80
pubmed: 12799274
J Neurosci. 1996 Oct 1;16(19):5986-92
pubmed: 8815881
Graefes Arch Clin Exp Ophthalmol. 2004 Jan;242(1):91-101
pubmed: 14685874
Nippon Ganka Gakkai Zasshi. 1997 Jul;101(7):564-70
pubmed: 9256617
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4435-43
pubmed: 17003437
Cell. 2001 Feb 23;104(4):545-56
pubmed: 11239411
Brain Res. 2000 Jan 3;852(1):217-20
pubmed: 10661516
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
J Neurochem. 2008 Apr;105(2):524-36
pubmed: 18088352
Prog Retin Eye Res. 2003 Jan;22(1):1-29
pubmed: 12597922
Science. 1996 Jan 26;271(5248):509-12
pubmed: 8560266
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9090-5
pubmed: 8799159
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):927-36
pubmed: 10711715
Circ Res. 2006 Jun 23;98(12):1479-89
pubmed: 16709900
Brain Res Mol Brain Res. 2000 Apr 14;77(1):125-30
pubmed: 10814838
Arch Ophthalmol. 1986 Feb;104(2):216-9
pubmed: 3947296
Neuroscience. 2003;122(1):229-35
pubmed: 14596863
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5759-67
pubmed: 20574028
Prog Retin Eye Res. 2009 Nov;28(6):423-51
pubmed: 19660572
J Med Chem. 2007 Apr 5;50(7):1675-84
pubmed: 17328532
Nature. 1990 Sep 6;347(6288):83-6
pubmed: 2168521
J Am Geriatr Soc. 1998 Apr;46(4):484-7
pubmed: 9560073
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):762-71
pubmed: 18235026
Chem Biol. 2006 Nov;13(11):1235-42
pubmed: 17114005
Glia. 2011 May;59(5):821-32
pubmed: 21360756
PLoS One. 2016 Jan 22;11(1):e0147312
pubmed: 26800359
Matrix Biol. 2000 Dec;19(7):615-22
pubmed: 11102750
J Mol Signal. 2013 Apr 23;8(1):5
pubmed: 23618372
J Clin Invest. 2001 May;107(9):1055-61
pubmed: 11342566
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Med. 2009 May;15(5):545-52
pubmed: 19412173
Nat Chem Biol. 2005 Jul;1(2):112-9
pubmed: 16408008
J Immunol. 2006 Oct 1;177(7):4267-70
pubmed: 16982859
Neuropharmacology. 2016 May;104:194-211
pubmed: 25998275
Hypertension. 2005 Jan;45(1):98-102
pubmed: 15557392
Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2361-2372
pubmed: 27520463
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):710-6
pubmed: 15309554
Am J Pathol. 2011 May;178(5):1975-85
pubmed: 21514415
Neuroscience. 2013 Aug 29;246:59-72
pubmed: 23639879
Mol Vis. 2015 Apr 09;21:360-77
pubmed: 25878490
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
PLoS Med. 2005 Sep;2(9):e251
pubmed: 16128620
Mol Cell Biol. 2006 Apr;26(7):2746-57
pubmed: 16537917
Nature. 2013 Apr 25;496(7446):518-22
pubmed: 23467095
Arch Ophthalmol. 2000 Mar;118(3):351-8
pubmed: 10721957
Purinergic Signal. 2018 Dec;14(4):471-484
pubmed: 30415294
Autophagy. 2013 Jul;9(7):973-84
pubmed: 23590900
Nature. 2013 Apr 25;496(7446):513-7
pubmed: 23467085
Mol Vis. 2014 Mar 03;20:242-58
pubmed: 24623967
Gynecol Oncol. 2009 Dec;115(3):371-6
pubmed: 19783287
Nature. 1998 Mar 26;392(6674):405-8
pubmed: 9537326

Auteurs

Margrit Hollborn (M)

Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany.

Ricarda Brück (R)

Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany.

Heidrun Kuhrt (H)

Institute of Anatomy, University of Leipzig, Germany.

Peter Wiedemann (P)

Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany.

Andreas Bringmann (A)

Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH